Shanghai Pharmaceuticals Holding Co.Ltd(601607) : reply from Shanghai Shangshi (Group) Co., Ltd. on abnormal fluctuation of Shanghai Pharmaceuticals Holding Co.Ltd(601607) stock trading Shanghai Pharmaceuticals Holding Co.Ltd(601607) : your inquiry email on abnormal fluctuation of Shanghai Pharmaceuticals Holding Co.Ltd(601607) stock trading sent on March 21 has been received. After verification by the company, the reply is as follows: Shanghai Tandong Enterprise Consulting Service Co., Ltd., a wholly-owned subsidiary of our company, as one of the subscribers, participated in the project of non-public offering of A-Shares in Shanghai Pharmaceuticals Holding Co.Ltd(601607) 2021. At present, the project has been approved by the issuance Audit Committee of CSRC. In addition, as of the date of this reply, the company has no major asset restructuring, share issuance, acquisition, debt restructuring, business restructuring, asset divestiture, asset injection, share repurchase, bankruptcy reorganization, major business cooperation, introduction of strategic investors and other major matters related to Shanghai Pharmaceuticals Holding Co.Ltd(601607)
© China Stock Market News